Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer--a review of the epidemiological evidence.
Strickler
H D
HD
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20852, USA.
Goedert
J J
JJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004279:DNA, Viral / Q000302:isolation & purification; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology / Q000821:virology*; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects / Q000737:chemistry*; D012307:Risk Factors; D013539:Simian virus 40 / Q000302:isolation & purification*; D014412:Tumor Virus Infections / Q000453:epidemiology*; D014611:Vaccination / Q000009:adverse effects
D004279:DNA, Viral; D011054:Poliovirus Vaccine, Inactivated